OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ALRTF.PK55

ALR Technologies SG Ltd

Advanced Medical Equipment & TechnologyVerified

ALR Technologies SG Ltd has a fully diluted share count of 645,466,844 shares, which is identical to its basic share count, indicating no dilution from stock options, warrants, or convertible securities at this time. However, the liquidity risk of the company could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and return metrics are not available for ALR Technologies SG Ltd, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data makes it difficult to compare the company's performance against industry benchmarks or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the extent of its international operations. Growth trajectory data is also not available, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. This absence of forward-looking guidance and historical performance data limits the ability to evaluate the company's growth potential. Risk factors for ALR Technologies SG Ltd include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments outstanding. However, the lack of financial data and disclosures increases the uncertainty around the company's financial health. Recent events, including filings and transcripts, are not available in the provided data. This absence of recent corporate activity or disclosures makes it difficult to assess any material developments that may have occurred in the company's operations or strategy.

30-day price · ALRTF.PK(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyALR Technologies SG Ltd
TickerALRTF.PK
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. ALR Technologies SG Ltd is a company engaged in the development and provision of advanced medical equipment and technology, primarily serving the healthcare services and equipment sector.

Classification. The company is classified under the Healthcare economic sector, within the Healthcare Services & Equipment business sector, and the Advanced Medical Equipment & Technology industry, with a confidence level of 0.92.

ALR Technologies SG Ltd has a fully diluted share count of 645,466,844 shares, which is identical to its basic share count, indicating no dilution from stock options, warrants, or convertible securities at this time. However, the liquidity risk of the company could not be assessed due to the absence of balance-sheet inputs and no going-concern language in the source documents. Profitability and return metrics are not available for ALR Technologies SG Ltd, as the valuation snapshot does not provide data on return on invested capital (ROIC), gross margins, or operating margins. This lack of data makes it difficult to compare the company's performance against industry benchmarks or cohort medians. The company's revenue concentration and geographic exposure are not disclosed in the available data. Without segment or geographic breakdowns, it is not possible to assess the diversification of its revenue streams or the extent of its international operations. Growth trajectory data is also not available, as the outlook for the current and next fiscal years does not include numeric deltas or revenue history. This absence of forward-looking guidance and historical performance data limits the ability to evaluate the company's growth potential. Risk factors for ALR Technologies SG Ltd include the inability to assess liquidity risk, which could impact the company's ability to meet short-term obligations. The dilution risk is currently low, as there is no evidence of dilutive instruments outstanding. However, the lack of financial data and disclosures increases the uncertainty around the company's financial health. Recent events, including filings and transcripts, are not available in the provided data. This absence of recent corporate activity or disclosures makes it difficult to assess any material developments that may have occurred in the company's operations or strategy.
Key takeaways
  • ALR Technologies SG Ltd operates in the Advanced Medical Equipment & Technology industry with a high classification confidence.
  • The company's share count is fully diluted, indicating no current dilution risk.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language.
  • Profitability metrics and growth outlook are not available, limiting the ability to evaluate performance and potential.
  • Revenue concentration and geographic exposure are not disclosed, making it difficult to assess diversification.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$7.5k-$3.0M-$8.4M
FY-3
FY-2
FY-1
FY0-$22.1M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$193.2k-$24.3M
FY-3
FY-2
FY-1
FY0-$39.9M
PeriodOCFCapExFCFSBC
FY-4-$1.8M
FY-3
FY-2
FY-1
FY0-$1.9M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2-$571.7k
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 109 companies
MetricALRTF.PKActivity
Op margin-19.9% medp25 -150.5% · p75 8.7%
Net margin-18.4% medp25 -146.8% · p75 8.0%
Gross margin49.9% medp25 36.2% · p75 66.3%
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-3.5% medp25 -7.8% · p75 -1.4%
Debt / equity14.5% medp25 0.9% · p75 54.2%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-05 00:27 UTC#7585c27e
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 08:19 UTCJob: e0b00024